Back to Report Store Home

Cancer Supportive Care Products Market to 2016 – Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars

  • Published: Apr-2011
  • Report Code: GBIHC082MR
  • Report Format: pdf

Description

GBI Research’s new report, “Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline Due to Generic Erosion and Entry of Biosimilars”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global Cancer Supportive Care Products market. The report analyzes the markets for Cancer Supportive Care Products in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales and prices are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

Scope

  • Annualized market data for the Cancer Supportive Care Products market from 2001 to 2009, forecast forward to 2016

  • Analysis of the leading therapeutic segments.

  • Analysis of the Cancer Supportive Care Products market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan

  • Market characterization of the Cancer Supportive Care Products market including market size, annual cost of therapy, and treatment usage patterns

  • Key drivers and barriers that have a significant impact on the market

  • Coverage of pipeline molecules in various phases of drug development

  • Competitive benchmarking of leading companies.

  • Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global Cancer Supportive Care Products market.

Reasons To Buy

  • Align your product portfolio to the markets with high growth potential.

  • Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth.

  • Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-class molecules with more efficiency and better safety.

  • Develop key strategic initiatives by understanding the key focus areas of leading companies.

  • Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps.

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards